CFM
Catalyst Funds Management Portfolio holdings
AUM
$362M
1-Year Return
42.71%
This Quarter Return
+10.52%
1 Year Return
+42.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$455M
AUM Growth
+$82.4M
(+22%)
Cap. Flow
+$61.8M
Cap. Flow
% of AUM
13.57%
Top 10 Holdings %
Top 10 Hldgs %
38.61%
Holding
1,671
New
529
Increased
423
Reduced
135
Closed
403
Top Buys
| 1 |
NVIDIA
NVDA
|
+$39.1M |
| 2 |
Microsoft
MSFT
|
+$27.7M |
| 3 |
Eli Lilly
LLY
|
+$12.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$7.21M |
| 5 |
Danaher
DHR
|
+$6.14M |
Top Sells
| 1 |
Apple
AAPL
|
+$68.6M |
| 2 |
Broadcom
AVGO
|
+$19.3M |
| 3 |
Nu Holdings
NU
|
+$15.9M |
| 4 |
Deckers Outdoor
DECK
|
+$7.92M |
| 5 |
Super Micro Computer
SMCI
|
+$6.23M |
Sector Composition
| 1 | Technology | 21.96% |
| 2 | Healthcare | 13.56% |
| 3 | Industrials | 12.93% |
| 4 | Communication Services | 11.22% |
| 5 | Financials | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
TruBridge
TBRG
$304M
| $25.1K | 0.01% |
2,100
| – | – |
|
1027
Columbia Sportswear
COLM
$3.03B
| $25K | 0.01% |
300
+200
| +200% | +$16.6K |
|
1028
Supernus Pharmaceuticals
SUPN
$2.61B
| $24.9K | 0.01% |
800
+700
| +700% | +$21.8K |
|
1029
Enviri
NVRI
$970M
| $24.8K | 0.01% |
2,400
+1,000
| +71% | +$10.3K |
|
1030
PRA Group
PRAA
$663M
| $24.6K | 0.01% |
1,100
+900
| +450% | +$20.1K |
|
|
CON
1031
Concentra Group Holdings Parent, Inc.
CON
$2.81B
| $24.6K | 0.01% |
+1,100
| New | +$24.6K |
|
1032
Cimpress
CMPR
$1.47B
| $24.6K | 0.01% |
+300
| New | +$24.6K |
|
1033
Foster
FSTR
$289M
| $24.5K | 0.01% |
+1,200
| New | +$24.5K |
|
1034
Helix Energy Solutions
HLX
$923M
| $24.4K | 0.01% |
2,200
+1,700
| +340% | +$18.9K |
|
|
SRCL
1035
DELISTED
Stericycle Inc
SRCL
| $24.4K | 0.01% |
+400
| New | +$24.4K |
|
1036
AdvanSix
ASIX
$571M
| $24.3K | 0.01% |
800
+200
| +33% | +$6.08K |
|
1037
Amylyx Pharmaceuticals
AMLX
$1.05B
| $24.3K | 0.01% |
7,500
| – | – |
|
1038
Cognex
CGNX
$7.5B
| $24.3K | 0.01% |
600
| – | – |
|
1039
Bristow Group
VTOL
$1.09B
| $24.3K | 0.01% |
+700
| New | +$24.3K |
|
|
CHX
1040
DELISTED
ChampionX
CHX
| $24.1K | 0.01% |
800
-2,800
| -78% | -$84.4K |
|
1041
Embecta
EMBC
$890M
| $24K | 0.01% |
1,700
+100
| +6% | +$1.41K |
|
1042
Alamos Gold
AGI
$13.9B
| $23.9K | 0.01% |
1,200
-2,400
| -67% | -$47.9K |
|
1043
ANI Pharmaceuticals
ANIP
$2.11B
| $23.9K | 0.01% |
+400
| New | +$23.9K |
|
|
HAYN
1044
DELISTED
Haynes International, Inc.
HAYN
| $23.8K | 0.01% |
+400
| New | +$23.8K |
|
1045
Karyopharm Therapeutics
KPTI
$55.4M
| $23.7K | 0.01% |
1,907
| – | – |
|
1046
Veritone
VERI
$178M
| $23.7K | 0.01% |
6,600
| – | – |
|
1047
Seer Inc
SEER
$117M
| $23.6K | 0.01% |
12,000
| – | – |
|
1048
American Public Education
APEI
$613M
| $23.6K | 0.01% |
+1,600
| New | +$23.6K |
|
1049
Seres Therapeutics
MCRB
$153M
| $23.6K | 0.01% |
1,245
| – | – |
|
1050
Virco
VIRC
$129M
| $23.5K | 0.01% |
+1,700
| New | +$23.5K |
|